医疗设备公司Embecta Corp（EMBC）今日盘中股价大幅下跌5.34%，尽管公司最新公布的季度业绩超出市场预期，但收入同比大幅下滑引发了投资者的担忧。
根据Embecta公布的截至3月31日的季度财报，公司调整后每股收益为0.70美元，显著高于分析师平均预期的0.53美元。然而，该季度营收同比下降9.8%至2.59亿美元，仅略高于分析师预期的2.5395亿美元。公司报告的季度净收入为2350万美元。
尽管Embecta的盈利能力超出预期，但收入的显著下滑似乎引发了投资者对公司长期增长前景的担忧。值得注意的是，该公司股价在本季度曾上涨4.3%，但今年迄今为止已下跌35.6%。分析师对该公司的平均评级为"持有"，12个月目标价中位数为20.00美元。今日的股价大跌反映了市场对Embecta未来业务发展的不确定性，投资者可能需要更多积极信号来重建信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.